Newsletter Subject

It sure sounds like subpoenas are coming for Kevin McCarthy and Jim Jordan

From

motherjones.com

Email Address

newsletters@motherjones.com

Sent On

Mon, Aug 2, 2021 07:40 PM

Email Preheader Text

August 2, 2021 The unprecedented political showdowns may have slowed since Donald Trump left office,

[View in browser]( [Mother Jones Daily Newsletter]( August 2, 2021 The unprecedented political showdowns may have slowed since Donald Trump left office, but the extraordinary clashes are all but certain to return soon, as the [threat of subpoenas]( for some of the most high-profile Trump loyalists grows. "I would support subpoenas to anybody who could shed light on that," Rep. Adam Kinzinger, one of the only two Republicans on the select committee to investigate the January 6 Capitol riot, [told ABC News on Sunday](. "If that's the leader, that's the leader." Kinzinger's willingness to subpoena his Republican colleagues is significant, even praiseworthy, considering the rest of the GOP's shameless efforts to completely rewrite the events of January 6, while members boycott congressional hearings into the Capitol attack altogether. So what happens if Republican members of Congress shun congressional subpoenas? As I noted over the weekend, we pretty much have no idea. But we can certainly expect a whole new level of shenanigans, courtesy once again of Trump's Republican Party. —Inae Oh Advertisement [House Donations Ad]( [Top Story] [Top Story]( [Evictions Are Coming. Democrats “Failed to Meet This Moment,” Say Democrats.]( Congressional efforts to extend the eviction moratorium failed on Friday. BY AJ VICENS [Trending] [It sure sounds like subpoenas are coming for Kevin McCarthy and Jim Jordan]( BY INAE OH [Here’s some depressing math: 3 Americans create enough carbon emissions to kill 1 person]( BY OLIVER MILMAN [Minneapolis just gave some coronavirus relief money to the police]( BY SAMANTHA MICHAELS [Your odds of going back to the office are dropping by the day]( BY NOAH LANARD Advertisement [House Subscriptions Ad]( [Health & Environment] [Special Feature]( [Is lab meat about to hit your dinner plate?]( Splashy headlines suggest it might be. But experts say it's still a “moonshot” away. BY TOM PHILPOTT [Fiercely Independent] Support from readers allows Mother Jones to do journalism that doesn't just follow the pack. [Donate]( [Recharge] SOME GOOD NEWS, FOR ONCE [“It Has Saved My Life”: MoJo Readers Reflect on 100 Years of Insulin]( The discovery of insulin 100 years ago “transformed diabetes from a death sentence to a chronic condition,” went the unflinching headline of a powerful [look back]( at the strides and disparities in treatment and outcomes by the Endocrine Society last week. The centennial was acutely personal for [many MoJo readers]( who wrote us with a mix of outrage at the obscenely high costs, celebration of the medical advances that save lives, and recognition of the vast work ahead. “Air” is how one reader describes the medicine that another reader says she has to “ration” to stay alive. Your responses got to the heart of the relief, anger, strength, and stamina that diabetes demands, but there was also big-picture acknowledgment of the milestone: “Each year on July 27, I toast Frederick Banting and Charles Best,” insulin’s discoverers, a reader tells us. “It has been 50 years since I started injecting daily doses, and it has saved my life.” Still, “the real expense is up to $1,000 a month” for a reader whose out-of-pocket cost is exorbitant. By contrast, an American living in the Netherlands tells us “there is no way I can afford to move back to the States” and keep getting insulin. “I’m lucky to live in the UK,” writes a reader whose insulin is subsidized. “I am enormously grateful for this and frankly horrified at the situation in the US, where one’s ability to control this condition, and remain alive, is related to wealth.” Care for family is a constant: “Insulin means that my little brother’s diagnosis of Type 1 diabetes at age 7 wasn’t a death sentence.” “My son’s blood will turn acidic within hours and he will die” without insulin. “I’m grateful for the discovery. But his insulin retails at $339.99 per vial.” Which is why seemingly abstract policy debates are so visceral for the reader who points out that “General Wesley Clark famously said when he announced his presidential candidacy that every American deserved the same excellent medical care he got. I’ve always believed that his statement, with which I very much agree, is what brought out the long knives to end his brief political career.” After co-pays and deductibles, “I still can’t afford” it, a reader writes, a pain point stemming from insulin’s patent: “Important for the story and often neglected is that the researchers who discovered insulin were reluctant to patent their process on grounds of medical ethics. Anyone suffering from the high cost of insulin needs to know that its discoverers at least wanted to ensure that it be widely available at low cost.” Our colleague Steve Katz, MoJo’s publisher, told me after I ran our [centennial piece]( last week that his son, Noah, who is diabetic, advocates for insulin justice. In a letter Steve shared with me that he’d written to thank a diabetes camp his family went to years ago, Steve summed up the tangible impact of support systems that “probably saved my son’s life. Noah was diagnosed with Type 1 [that] summer [and] we could see that it wasn’t about camp per se…It was about the fact that, being there, Noah had to face directly that he really did have this disease, it wasn’t going to go away, and his life had changed forever…Each [counselor] would sit with him at a meal or hang out with him in the ‘shot line’ where kids get their blood sugars checked and insulin dosed, and give their story of how it was for them and how it is and will be for him. And Noah saw that he could survive this. The experience was literally transformative.” Steve wrote those words eight years ago. Reading it now makes me look ahead: In eight more years, on the 108th anniversary of insulin, will you, readers, tell us again how you’ve survived not just diabetes but the still-staggering costs of its treatment in the [wealthiest country in the world](? As another reader tells us, “We should not need a coupon or ‘program’ to” stay alive. Happy 100th. Keep stories coming to recharge@motherjones.com. —Daniel King Did you enjoy this newsletter? Help us out by [forwarding]( it to a friend or sharing it on [Facebook]( and [Twitter](. [Mother Jones]( [Donate]( [Subscribe]( This message was sent to {EMAIL}. To change the messages you receive from us, you can [edit your email preferences]( or [unsubscribe from all mailings.]( For advertising opportunities see our online [media kit.]( Were you forwarded this email? [Sign up for Mother Jones' newsletters today.]( [www.MotherJones.com]( PO Box 8539, Big Sandy, TX 75755

Marketing emails from motherjones.com

View More
Sent On

09/11/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

05/11/2024

Sent On

29/10/2024

Sent On

27/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.